Latest hypertension Stories
Blood Pressure Reduction Guide made by Paul Johnson is the latest program for hypertension sufferers who want to lower the risk of a heart attack or stroke.
The global market for peripheral vascular surgical devices was valued at $5.8 billion in 2012 and at $6.2 billion for 2013.
-- Bayer's Adempas (riociguat tablets) approved for the treatment of pulmonary arterial hypertension (PAH)(1), which affects up to 2000 Canadians(2) -- Adempas provides
Live Well Medical Centers Orlando’s Primary focus is prevention of illness, with a team of Internal Medicine, Primary Care, and Family Medicine specialists using a progressive approach with
New research has discovered a possible link between differences in interarm blood pressure and an increased risk of a future cardiovascular event, presenting new evidence to support the belief that diagnostic tests should be measured in both arms.
A new study, published in the journal JAMA Internal Medicine, reveals that medications used by many older people to control their blood pressure also increases the risk of serious fall injuries by 30 to 40 percent.
On Rare Disease Day, February 28, the Pulmonary Hypertension Association and PH community will celebrate the approval of three new PH treatments since October 2013 and join the National Organization
A new research review from a joint team of Japanese and American doctors has found that switching to a vegetarian diet can be an effective means for lowering blood pressure.
Hypertension is a peer-reviewed scientific journal established in 1979 and published monthly by the American Heart Association (AHA). As of May 2012, the editor-in-chief is John E. Hall (University of Mississippi). Publishing formats include original manuscripts, invited review summaries, invited case-based reviews, recent study highlights, invited brief commentaries, scientific or technical tutorials, letter to the editor, and novel findings of unusual interest. This journal focuses on...